A CRITICAL-ASSESSMENT OF CANCER-CHEMOTHERAPY - INTRODUCTION - A HISTORY OF THE PROGRESS OF ANTICANCER CHEMOTHERAPY

被引：0
|
作者：
CALVERT, AH
机构：
来源：
CANCER SURVEYS | 1989年 / 8卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：493 / 509
页数：17
相关论文
共 50 条
  • [21] PRODRUGS IN CANCER-CHEMOTHERAPY
    WILMAN, DEV
    BIOCHEMICAL SOCIETY TRANSACTIONS, 1986, 14 (02) : 375 - 382
  • [22] CANCER-CHEMOTHERAPY IN THE ELDERLY
    WALSH, SJ
    BEGG, CB
    CARBONE, PP
    SEMINARS IN ONCOLOGY, 1989, 16 (01) : 66 - 75
  • [23] COMPLIANCE AND CANCER-CHEMOTHERAPY
    GREEN, JA
    BRITISH MEDICAL JOURNAL, 1983, 287 (6395): : 778 - 779
  • [24] INDICATIONS FOR CANCER-CHEMOTHERAPY
    OMURA, GA
    NEW ENGLAND JOURNAL OF MEDICINE, 1982, 307 (13): : 826 - 826
  • [25] CHEMOEMBOLISM IN CANCER-CHEMOTHERAPY
    KERR, DJ
    KAYE, SB
    CRITICAL REVIEWS IN THERAPEUTIC DRUG CARRIER SYSTEMS, 1991, 8 (01): : 19 - 37
  • [26] NABILONE AND CANCER-CHEMOTHERAPY
    STARK, P
    ANNALS OF INTERNAL MEDICINE, 1982, 96 (01) : 122 - 122
  • [27] CANCER-CHEMOTHERAPY - REPLY
    FREI, E
    SCIENCE, 1983, 220 (4594) : 254 - +
  • [28] CYCLOCREATINE IN CANCER-CHEMOTHERAPY
    TEICHER, BA
    MENON, K
    NORTHEY, D
    LIU, J
    KUFE, DW
    KADDURAHDAOUK, R
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1995, 35 (05) : 411 - 416
  • [29] NEOCARZINOSTATIN IN CANCER-CHEMOTHERAPY
    MAEDA, H
    ANTICANCER RESEARCH, 1981, 1 (03) : 175 - 185
  • [30] COMPLIANCE AND CANCER-CHEMOTHERAPY
    SMEDLEY, H
    BRATHERTON, D
    SIKORA, K
    BRITISH MEDICAL JOURNAL, 1983, 287 (6398): : 1067 - 1068
12345